Z-Pak carries increased risk of heart disease, study says - WSMV News 4

Z-Pak carries increased risk of heart disease, study says

Posted: Updated:
NASHVILLE, TN (WSMV) -

A recent Vanderbilt University study now has the FDA taking note about the dangers of a popular antibiotic.

The Food and Drug Administration is warning patients about the drug Azithromycin. It's commonly sold under the name Zithromax in what's called a Z-Pak and is used to treat bacterial infections.

However, Vanderbilt researchers found an increased risk of death from heart disease in the first five days of using a Z-Pak when compared to other common antibiotics or no antibiotics.

The FDA said patients who have pre-existing heart problems or low blood levels of potassium or magnesium are at a higher risk.

Pfizer, which produces the drug, said the majority of patients using the antibiotic are not affected.

Copyright 2013 WSMV (Meredith Corporation). All rights reserved.

Powered by Frankly
WSMV
Powered by WorldNow CNN
All content © 2017, WSMV; Nashville, TN. (A Meredith Corporation Station) . All Rights Reserved.
For more information on this site, please read our Privacy Policy, and Terms of Service, and Ad Choices.